Stage IV Squamous Cell Lung Carcinoma
3 clinical trials · Condition
◉ Watch Stage IV Squamous Cell Lung Carcinoma
| Record | Firm | Date |
|---|---|---|
| Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer (NCT02536495) | Erin Bertino | 2015-09-01 |
| Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches (NCT02785913) | SWOG Cancer Research Network | 2014-11-01 |
| S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT00946712) | SWOG Cancer Research Network | 2009-07-15 |
Track Stage IV Squamous Cell Lung Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.